Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fridkin

Showing results (181-190 of 515) with videos related to

Pageof 52
Sort By:
Neurochemical Research|May 5, 1998
Protection against developmental deficiencies by a lipophilic VIP analogueI Gozes, M Bachar, A Bardea, et al.
International Journal of Peptide and Protein Research|February 1, 1987
Synthesis of modified tuftsins containing monosaccharides or monosaccharide derivativesR Rocchi, L Biondi, F Filira, et al.
Bioconjugate Chemistry|July 21, 2005
Albumin-insulin conjugate releasing insulin slowly under physiological conditions: a new concept for long-acting insulinYoram Shechter, Marina Mironchik, Sara Rubinraut, et al.
International Journal of Peptide and Protein Research|March 1, 1991
Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor productionR Rocchi, L Biondi, F Filira, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1989
Potential use of tuftsin in treatment of candida peritonitis in a murine modelR Levy, Z Kain, C Chaimovitz, et al.
Nanomaterials (Basel, Switzerland)|September 18, 2020
Polarization Switching in 2D Nanoscale Ferroelectrics: Computer Simulation and Experimental Data AnalysisEkaterina Paramonova, Vladimir Bystrov, Xiangjian Meng, et al.
Regulatory Peptides|November 1, 2002
In vitro and in vivo treatment of colon cancer by VIP antagonistsAlbert Levy, Rivka Gal, Ruth Granoth, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 23, 1999
Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivativesP Gressens, L Besse, P Robberecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1978
Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cellsE Tzehoval, S Segal, Y Stabinsky, et al.
Pediatrics|May 3, 2006
Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004Scott K Fridkin, David Kaufman, Jonathan R Edwards, et al.
Pageof 52

Showing results (181-190 of 515) with videos related to

Sort By:
Pageof 52
Neurochemical Research|May 5, 1998
Protection against developmental deficiencies by a lipophilic VIP analogueI Gozes, M Bachar, A Bardea, et al.
International Journal of Peptide and Protein Research|February 1, 1987
Synthesis of modified tuftsins containing monosaccharides or monosaccharide derivativesR Rocchi, L Biondi, F Filira, et al.
Bioconjugate Chemistry|July 21, 2005
Albumin-insulin conjugate releasing insulin slowly under physiological conditions: a new concept for long-acting insulinYoram Shechter, Marina Mironchik, Sara Rubinraut, et al.
International Journal of Peptide and Protein Research|March 1, 1991
Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor productionR Rocchi, L Biondi, F Filira, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1989
Potential use of tuftsin in treatment of candida peritonitis in a murine modelR Levy, Z Kain, C Chaimovitz, et al.
Nanomaterials (Basel, Switzerland)|September 18, 2020
Polarization Switching in 2D Nanoscale Ferroelectrics: Computer Simulation and Experimental Data AnalysisEkaterina Paramonova, Vladimir Bystrov, Xiangjian Meng, et al.
Regulatory Peptides|November 1, 2002
In vitro and in vivo treatment of colon cancer by VIP antagonistsAlbert Levy, Rivka Gal, Ruth Granoth, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 23, 1999
Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivativesP Gressens, L Besse, P Robberecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1978
Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cellsE Tzehoval, S Segal, Y Stabinsky, et al.
Pediatrics|May 3, 2006
Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004Scott K Fridkin, David Kaufman, Jonathan R Edwards, et al.
Pageof 52